NCT07094893 2026-01-14
ARIEL-ENGIC
Gruppo Oncologico del Nord-Ovest
Phase 4 Not yet recruiting
Clinical Trials
16 trialsNCT07158164 2025-11-13
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Rutgers, The State University of New Jersey
Phase 4 Recruiting
NCT06090994 2025-05-07
Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy
Fudan University
Phase 4 Recruiting
NCT06550453 2024-11-12
Safety and Efficacy of Pembrolizumab in Combination with Bevacizumab + CapeOX in the Neoadjuvant Treatment of RAS-mutated, BRAF Wild-type, Microsatellite-stabilized, Locally Advanced Colorectal Cancer
Xijing Hospital
Phase 4 Recruiting
NCT06387368 2024-04-29
Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer
Xi'an Jiaotong University
Phase 4 Not yet recruiting
NCT01588990 2019-01-22
ASCENT
Hoffmann-La Roche
Phase 4 Completed
NCT00812864 2018-08-28
capagec
University Hospital, Limoges
Phase 4 Completed
NCT03465202 2018-03-14
Association of Capecitabine Pharmacokinetics and Toxicity With Aging
Newcastle-upon-Tyne Hospitals NHS Trust
Phase 4 Unknown
NCT02567331 2016-11-02
A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT02581423 2016-11-02
A Study of Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT01641458 2016-02-02
FLOXTOX2
Cantonal Hospital of St. Gallen
Phase 4 Completed
NCT00502671 2015-09-03
A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer.
Hoffmann-La Roche
Phase 4 Completed
NCT02380131 2015-03-05
Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis
Hebei Medical University
Phase 4 Unknown
NCT01962376 2013-10-14
Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver Metastasis
Hebei Medical University
Phase 4 Unknown
NCT00220168 2009-12-16
Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours
Royal Marsden NHS Foundation Trust
Phase 4 Completed
NCT00216424 2007-11-12
Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma
James A. Haley Veterans Administration Hospital
Phase 4 Terminated